Get ready to be transported back to the golden age of jazz with toe-tapping rhythms, heartfelt melodies, and soulful vocals that will have you swinging and swinging all night long. Whether you're a ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...

TG4050 is an individualized immunotherapy being developed for solid tumors that is based on Transgene’s myvac® technology and powered by NEC’s longstanding artificial intelligence (AI) expertise.

PRAGUE & BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, today announced it will present a Trial-in-Progress poster on the ...

MeiraGTx will present four posters at the ASGCT 2025 Annual Meeting regarding genetic therapies for obesity and ALS. Quiver AI Summary MeiraGTx Holdings plc announced its participation in the American ...

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. ("Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present ...

As the final event held in conjunction with the exhibition Fallout: Atoms for War & Peace, Poster House is thrilled to partner with Sing for Science to host the groundbreaking artist and activist ...

-SLS-005 induces autophagy to reduce mutant protein aggregates, and is currently being studied in Alzheimer's disease, Huntington's disease, Amyotrophic Lateral Sclerosis and Spinocerebellar ataxia In ...